CLPBY Coloplast A/S Sponsored ADRs

Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Interventional Urology segment covers the sale of urological products, including disposable products. The Wound & Skin Care segment covers the sale of wound and skin care products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark. This is an ADR of a company whose stock trades outside of the U.S. as the symbol DC:COLO-B.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$15.26    Pink
As of 01/14/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Large cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  Denmark
Country of incorporation:  Denmark
IPO date:  01/13/2014
Outstanding shares:  1,980,000,000
Average volume:  64,574
Market cap:   $30,412,800,000
Current dividend yield:  1.93%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   6.26
PB ratio:   3.98
PS ratio:   1.57
Return on equity:   59.07%
Net income %:   24.84%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy